Andrea A Pappalardo1, Kelly Karavolos2, Molly A Martin3. 1. Asthma and Allergy Center, Bloomingdale, Ill; Department of Pediatrics, University of Illinois at Chicago, Chicago, Ill. Electronic address: pappalardo.andrea@gmail.com. 2. Department of Preventative Medicine, Rush University Medical Center, Chicago, Ill. 3. Department of Pediatrics, University of Illinois at Chicago, Chicago, Ill.
Abstract
BACKGROUND: Asthma disproportionately affects minority youth. Understanding the home medication environment and its relation to medication adherence can shape interventions to improve health outcomes. OBJECTIVE: The objective of this study was to describe the asthma medication environment in the homes of urban minority youth and to determine predictors of medication use and technique in this population. METHODS: Baseline data from 2 cohorts of minority youth with asthma in Chicago were combined for cross-sectional analysis. Bilingual research assistants (RAs) collected data in the home. RAs asked caregivers and children to self-report medications using pictures and observed children's asthma medications and inhaler technique. RESULTS: The sample contained 175 mainly Latino youth (85.6%) ranging from 5 to 18 years old. Most were on public insurance (80%) and had uncontrolled asthma by self-report (89.7%). Only 27.4% had a spacer, 74.9% had a quick relief medicine, and 48.6% had any controller medicine. RA observations of controllers agreed with children (36%) and parental self-report (42.3%) but did not match the specific observed controllers. Children reported less parental help with medications (43%) than their parents (58.1%). One child was able to properly demonstrate 100% of the inhaler steps and 35.6% achieved >70% of inhaler steps. A better medication technique was associated with having a controller (b = 12.2, SE = 3.0, P < .0001), quick reliever (b = 8.05, SE = 3.5, P = .023), and a spacer (b = 9.3, SE = 3.54, P = .009). CONCLUSIONS: This rigorous evaluation of the home medication environment of high-risk youth demonstrated that many families lack critical medications, devices, and a technique for proper management of asthma.
RCT Entities:
BACKGROUND:Asthma disproportionately affects minority youth. Understanding the home medication environment and its relation to medication adherence can shape interventions to improve health outcomes. OBJECTIVE: The objective of this study was to describe the asthma medication environment in the homes of urban minority youth and to determine predictors of medication use and technique in this population. METHODS: Baseline data from 2 cohorts of minority youth with asthma in Chicago were combined for cross-sectional analysis. Bilingual research assistants (RAs) collected data in the home. RAs asked caregivers and children to self-report medications using pictures and observed children's asthma medications and inhaler technique. RESULTS: The sample contained 175 mainly Latino youth (85.6%) ranging from 5 to 18 years old. Most were on public insurance (80%) and had uncontrolled asthma by self-report (89.7%). Only 27.4% had a spacer, 74.9% had a quick relief medicine, and 48.6% had any controller medicine. RA observations of controllers agreed with children (36%) and parental self-report (42.3%) but did not match the specific observed controllers. Children reported less parental help with medications (43%) than their parents (58.1%). One child was able to properly demonstrate 100% of the inhaler steps and 35.6% achieved >70% of inhaler steps. A better medication technique was associated with having a controller (b = 12.2, SE = 3.0, P < .0001), quick reliever (b = 8.05, SE = 3.5, P = .023), and a spacer (b = 9.3, SE = 3.54, P = .009). CONCLUSIONS: This rigorous evaluation of the home medication environment of high-risk youth demonstrated that many families lack critical medications, devices, and a technique for proper management of asthma.
Authors: Jerry A Krishnan; Kristin A Riekert; Jonathan V McCoy; Dana Y Stewart; Spencer Schmidt; Arjun Chanmugam; Peter Hill; Cynthia S Rand Journal: Am J Respir Crit Care Med Date: 2004-09-16 Impact factor: 21.405
Authors: Emmanuelle M Clerisme-Beaty; Susan J Bartlett; W Gerald Teague; John Lima; Charles G Irvin; Rubin Cohen; Mario Castro; Robert A Wise; Cynthia S Rand Journal: J Allergy Clin Immunol Date: 2011-02 Impact factor: 10.793
Authors: L Keoki Williams; Edward L Peterson; Karen Wells; Brian K Ahmedani; Rajesh Kumar; Esteban G Burchard; Vimal K Chowdhry; David Favro; David E Lanfear; Manel Pladevall Journal: J Allergy Clin Immunol Date: 2011-10-21 Impact factor: 10.793
Authors: Jerry A Krishnan; Bruce G Bender; Frederick S Wamboldt; Stanley J Szefler; N Franklin Adkinson; Robert S Zeiger; Robert A Wise; Andrew L Bilderback; Cynthia S Rand Journal: J Allergy Clin Immunol Date: 2011-11-21 Impact factor: 10.793
Authors: Valerie G Press; Vineet M Arora; Lisa M Shah; Stephanie L Lewis; Krystal Ivy; Jeffery Charbeneau; Sameer Badlani; Edward Nareckas; Edward Naurekas; Antoinette Mazurek; Jerry A Krishnan Journal: J Gen Intern Med Date: 2011-01-20 Impact factor: 5.128
Authors: Philippe Latry; Marion Pinet; Anne Labat; Jean-Pierre Magand; Claude Peter; Philip Robinson; Karin Martin-Latry; Mathieu Molimard Journal: Clin Ther Date: 2008 Impact factor: 3.393
Authors: Henry K Litt; Valerie G Press; Ashley Hull; Michelle Siros; Viridiana Luna; Anna Volerman Journal: Respir Med Date: 2020-10-09 Impact factor: 3.415
Authors: Jennifer A Callaghan-Koru; Kristin A Riekert; Elizabeth Ruvalcaba; Cynthia S Rand; Michelle N Eakin Journal: Pediatrics Date: 2018-08-07 Impact factor: 7.124
Authors: Christina Crabtree-Ide; Denise F Lillvis; Jing Nie; Maria Fagnano; Reynaldo S Tajon; Paul Tremblay; Jill S Halterman; Katia Noyes Journal: Popul Health Manag Date: 2021-05-14 Impact factor: 2.459